4.7 Article

Spontaneous Network Events Driven by Depolarizing GABA Action in Neonatal Hippocampal Slices are Not Attributable to Deficient Mitochondrial Energy Metabolism

期刊

JOURNAL OF NEUROSCIENCE
卷 30, 期 46, 页码 15638-15642

出版社

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.3355-10.2010

关键词

-

资金

  1. Academy of Finland
  2. Sigrid Juselius Foundation
  3. Jane and Aatos Erkko Foundation

向作者/读者索取更多资源

In two recent papers (Rheims et al., 2009; Holmgren et al., 2010), Zilberter and coworkers argue that the well known depolarizing GABA actions that take place at the cellular and network level in the neonatal hippocampus and neocortex in vitro are pathophysiological phenomena, attributable to deficient mitochondrial energy metabolism. In their experiments, supplementing the glucose-containing solution with weak-acid substrates of mitochondrial energy metabolism (such as beta-hydroxy-butyrate, lactate, or pyruvate) abolished the spontaneous network events (giant depolarizing potentials; GDPs) and the underlying depolarizing actions of GABA. In this study, we made electrophysiological recordings of GDPs and monitored the mitochondrial membrane potential (Psi m) and intracellular pH (pH(i)) in CA3 neurons in neonatal rat hippocampal slices. Supplementing the standard physiological solution with L-lactate did not produce a change in Psi m, whereas withdrawal of glucose, in the presence or absence of L-lactate, was followed by a pronounced depolarization of Psi m. Furthermore, D-lactate (a poor substrate of mitochondrial metabolism) caused a prompt inhibition in GDP frequency which was similar to the effect of L-lactate. The suppression of GDPs was strictly proportional to the fall in pH(i) caused by weak carboxylic acids (L-lactate, D-lactate, or propionate) or by an elevated CO2. The main conclusions of our work are that the inhibitory effect of L-lactate on GDPs is not mediated by mitochondrial energy metabolism, and that glucose at its standard 10 mM concentration is an adequate energy substrate for neonatal neurons in vitro. Notably, changes in pH(i) appear to have a very powerful modulatory effect on GDPs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

A physiologically validated rat model of term birth asphyxia with seizure generation after, not during, brain hypoxia

Tommi Ala-Kurikka, Alexey Pospelov, Milla Summanen, Aleksander Alafuzoff, Samu Kurki, Juha Voipio, Kai Kaila

Summary: A rat model of birth asphyxia was developed to mimic clinical cases, showing that seizures are triggered after exposure to hypoxia, rather than during the insult.

EPILEPSIA (2021)

Review Neurosciences

The Multifaceted Roles of KCC2 in Cortical Development

Mari A. Virtanen, Pavel Uvarov, Martina Mavrovic, Jean Christophe Poncer, Kai Kaila

Summary: KCC2 is a multifunctional molecule that can regulate the strength and polarity of GABAergic currents and cytoskeletal dynamics. Its various splice variants play roles in controlling early network events and the formation and plasticity of cortical dendritic spines. The versatility of KCC2 actions is evident in mature neurons during plasticity, disease, and aging, making it one of the most important molecules shaping the overall neuronal phenotype.

TRENDS IN NEUROSCIENCES (2021)

Article Biochemistry & Molecular Biology

Carbonic anhydrase seven bundles filamentous actin and regulates dendritic spine morphology and density

Enni Bertling, Peter Blaesse, Patricia Seja, Elena Kremneva, Gergana Gateva, Mari A. Virtanen, Milla Summanen, Inkeri Spoljaric, Pavel Uvarov, Michael Blaesse, Ville O. Paavilainen, Laszlo Vutskits, Kai Kaila, Pirta Hotulainen, Eva Ruusuvuori

Summary: Intracellular pH is regulated by carbonic anhydrase isoforms CA2 and CA7 in neurons. CA7 interacts with actin, affecting cell morphology, while unique amino acids in CA7 promote actin interaction and influence spine density in neurons.

EMBO REPORTS (2021)

Review Clinical Neurology

Reply to the commentary by Ben-Ari and Delpire: Bumetanide and neonatal seizures: Fiction versus reality

Wolfgang Loescher, Kai Kaila

Summary: This response corrects the inaccurate descriptions of the model and data in a recent study on the pharmacology of neonatal seizures in a novel rat model of birth asphyxia by Ben-Ari and Delpire. The authors also address the implications of bumetanide actions on neurons in other brain disorders due to its poor brain penetration and wide cellular expression patterns of the target protein NKCC1.

EPILEPSIA (2021)

Article Neurosciences

Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsy

Philip Hampel, Marie Johne, Bjoern Gailus, Alexandra Vogel, Alina Schidlitzki, Birthe Gericke, Kathrin Toellner, Wiebke Theilmann, Christopher Kaeufer, Kerstin Roemermann, Kai Kaila, Wolfgang Loescher

Summary: The study investigated the effects of NKCC1 expression on seizures and epilepsy using KO and WT mice. Results showed that while NKCC1 deficiency did not affect the induction and progression of epilepsy, it led to a more severe epileptic phenotype.

NEUROBIOLOGY OF DISEASE (2021)

Article Biochemistry & Molecular Biology

The NKCC1 ion transporter modulates microglial phenotype and inflammatory response to brain injury in a cell-autonomous manner

Krisztina Toth, Nikolett Lenart, Peter Berki, Rebeka Fekete, Eszter Szabadits, Balazs Posfai, Csaba Cserep, Ahmad Alatshan, Szilvia Benko, Daniel Kiss, Christian A. Huebner, Attila Gulyas, Kai Kaila, Zsuzsanna Koernyei, Adam Denes

Summary: The NKCC1 ion transporter has an important role in microglia, the main inflammatory cells of the brain, by regulating cellular morphology, volume changes, and inflammatory responses. Microglial NKCC1 deficiency leads to exaggerated inflammation and worsened neurological outcomes.

PLOS BIOLOGY (2022)

Editorial Material Clinical Neurology

Bumetanide for neonatal seizures: No light in the pharmacokinetic/dynamic tunnel

Kai Kaila, Wolfgang Loescher

Summary: This article responds to Kevin Staley's critique of our research, explaining that our study was conducted on an asphyxia model, not just hypercarbia; clinically relevant doses of bumetanide lead to significantly lower concentrations in the brain than what is needed for any direct effect on neuronal functions; furthermore, bumetanide's molecular target in the brain has vital functions that make specifically targeting the depolarizing and excitatory actions of gamma-aminobutyric acid in neonatal seizures difficult.

EPILEPSIA (2022)

Article Biochemistry & Molecular Biology

A cross-species spatiotemporal proteomic analysis identifies UBE3A-dependent signaling pathways and targets

Nikhil J. Pandya, Sonja Meier, Stefka Tyanova, Marco Terrigno, Congwei Wang, A. Mattijs Punt, E. J. Mientjes, Audrey Vautheny, Ben Distel, Thomas Kremer, Ype Elgersma, Ravi Jagasia

Summary: This study investigates the mechanisms and potential therapeutic options for Angelman syndrome. Proteomics analysis reveals changes in protein pathways during different stages of development in an AS mouse model. Restoring UBE3A expression is shown to reverse these changes and provide a promising treatment option. Additionally, a novel UBE3A substrate is discovered, and a protein database is created to support future research.

MOLECULAR PSYCHIATRY (2022)

Article Neurosciences

CNS pharmacology of NKCC1 inhibitors*

Wolfgang Loescher, Kai Kaila

Summary: Current NKCC1 inhibitors like bumetanide have limited penetration into the CNS, leading to the need for further research to develop brain-permeant compounds that are selective for NKCC1. Another challenge is to understand the effects of these drugs on different NKCC1-expressing cellular targets within and outside the brain parenchyma.

NEUROPHARMACOLOGY (2022)

Article Neurosciences

Expression patterns of NKCC1 in neurons and non-neuronal cells during cortico-hippocampal development

Samu N. Kurki, Pavel Uvarov, Alexey S. Pospelov, Kalevi Trontti, Antje K. Huebner, Rakenduvadhana Srinivasan, Masahiko Watanabe, Iiris Hovatta, Christian A. Huebner, Kai Kaila, Mari A. Virtanen

Summary: The widely expressed Na-K-2Cl cotransporter NKCC1 has been hindered in its understanding of its roles in brain functions and disorders due to lack of reliable data on its developmental and (sub)cellular expression patterns. This study provides a well-controlled analysis of NKCC1 protein expression in different cell types of the mouse brain and reveals its high levels in oligodendrocytes, differential expression in neurons, microglia, astrocytes, developing pericytes, and progenitor cells of the dentate gyrus, and the presence of NKCC1 splice variants. These findings contribute to our understanding of NKCC1 functions in the brain and have implications for the development of neuron-targeting NKCC1-blockers.

CEREBRAL CORTEX (2023)

Article Neurosciences

Carbogen-Induced Respiratory Acidosis Blocks Experimental Seizures by a Direct and Specific Inhibition of NaV1.2 Channels in the Axon Initial Segment of Pyramidal Neurons

Robert J. Hatch, Geza Berecki, Nikola Jancovski, Melody Li, Ben Rollo, Paymaan Jafar-Nejad, Frank Rigo, Kai Kaila, Christopher A. Reid, Steven Petrou

Summary: Brain pH plays a critical role in determining neuronal activity, with alkalosis increasing excitability and acidosis reducing it. This study investigates the molecular mechanisms behind the seizure protection observed when brain pH shifts through the inhalation of carbogen. The findings suggest that acidification reduces excitability in excitatory neurons but has no effect on inhibitory neurons, providing insight into the basis of seizure suppression caused by carbogen-mediated acidification.

JOURNAL OF NEUROSCIENCE (2023)

Article Clinical Neurology

SLC4A10 mutation causes a neurological disorder associated with impaired GABAergic transmission

James Fasham, Antje K. Huebner, Lutz Liebmann, Reham Khalaf-Nazzal, Reza Maroofian, Nderim Kryeziu, Saskia B. Wortmann, Joseph S. Leslie, Nishanka Ubeyratna, Grazia M. S. Mancini, Marjon van Slegtenhorst, Martina Wilke, Tobias B. Haack, Hanan E. Shamseldin, Joseph G. Gleeson, Mohamed Almuhaizea, Imad Dweikat, Bassam Abu-Libdeh, Muhannad Daana, Maha S. Zaki, Matthew N. Wakeling, Lucy McGavin, Peter D. Turnpenny, Fowzan S. Alkuraya, Henry Houlden, Peter Schlattmann, Kai Kaila, Andrew H. Crosby, Emma L. Baple, Christian A. Huebner

Summary: A novel neurodevelopmental disorder associated with biallelic pathogenic variants in SLC4A10 has been identified, which exhibits learning difficulties, seizures, and characteristic brain imaging features. Dysfunction of GABAergic transmission may contribute to the disorder.
Article Immunology

A brain cytokine-independent switch in cortical activity marks the onset of sickness behavior triggered by acute peripheral inflammation

Samu N. Kurki, Tommi Ala-Kurikka, Arto Lipponen, Alexey S. Pospelov, Taisia Rolova, Jari Koistinaho, Juha Voipio, Kai Kaila

Summary: Systemic inflammation induces both protective and pro-inflammatory responses in the brain, leading to disrupted cognition. The mechanisms underlying the peripheral-central inflammatory signaling are not fully understood.

JOURNAL OF NEUROINFLAMMATION (2023)

Article Cell Biology

Acute neuroinflammation leads to disruption of neuronal chloride regulation and consequent hyperexcitability in the dentate gyrus

Samu N. Kurki, Rakenduvadhana Srinivasan, Jens Laine, Mari A. Virtanen, Tommi Ala-Kurikka, Juha Voipio, Kai Kaila

Summary: Acute neuroinflammation leads to hyperexcitability in dentate gyrus (DG) neurons, caused by disruption of neuronal chloride regulation and loss of GABAergic inhibition, resulting in cognitive impairment.

CELL REPORTS (2023)

Meeting Abstract Clinical Neurology

Long-term outcome in a novel rat model of birth asphyxia and neonatal seizures matches with clinical findings: Paving the way for prevention studies

Bjoern Gailus, Hannah Naundorf, Lisa Welzel, Marie Johne, Kerstin Roemermann, Kai Kaila, Wolfgang Loescher

EPILEPSIA (2021)

暂无数据